Skip to main content
Top
Published in: BMC Pediatrics 1/2019

Open Access 01-12-2019 | Epilepsy | Case report

Cleidocranial dysplasia syndrome with epilepsy: a case report

Authors: Yimei Ma, Fumin Zhao, Dan Yu

Published in: BMC Pediatrics | Issue 1/2019

Login to get access

Abstract

Background

Cleidocranial dysplasia is a rare autosomal dominant disorder resulting in skeletal and dental abnormalities due to the disturbance in ossification of the bones. The prevalence of CCD is one in a million of live births, and epileptic seizures are rarer in this disease.

Case presentation

Herein, we present a case of a 10-year-old girl, who not only suffered with cleidocranial dysplasia, but experienced frequent seizures. We initiated an anti-epileptic treatment for this patient with dose adjustments to her weight of levetiracetam (10 mg/kg, bid) for 3 months. The epileptic seizures were controlled, but the intelligence level and control of epilepsy need to be followed up for a longer duration.

Conclusions

In clinical practice, if a patient has unusual facies, typical clavicle defect, skull bone enlargement, and unclosed anterior fontanelle, we should consider the possibility of cleidocranial dysplasia, genetic detection are helpful to make a confirmed diagnosis. In such cases, early diagnosis and treatment is important to correct deformities and improve the quality of life of patients.
Literature
1.
go back to reference Machol K, Mendoza-Londono R, Lee B. Cleidocranial Dysplasia Spectrum Disorder. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews®. Seattle (WA); 1993. Machol K, Mendoza-Londono R, Lee B. Cleidocranial Dysplasia Spectrum Disorder. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews®. Seattle (WA); 1993.
2.
go back to reference Callea M, Bellacchio E, Di Stazio M, Fattori F, Bertini E, Yavuz I, Clarich G, Gunay A. A case of cleidocranial dysplasia with peculiar dental features: pathogenetic role of the RUNX2 mutation and long term follow-up. Oral Health Dent Manage. 2014;13(2):548–51. Callea M, Bellacchio E, Di Stazio M, Fattori F, Bertini E, Yavuz I, Clarich G, Gunay A. A case of cleidocranial dysplasia with peculiar dental features: pathogenetic role of the RUNX2 mutation and long term follow-up. Oral Health Dent Manage. 2014;13(2):548–51.
3.
go back to reference Cooper SC, Flaitz CM, Johnston DA, Lee B, Hecht JT. A natural history of cleidocranial dysplasia. Am J Med Genet. 2001;104(1):1–6.CrossRef Cooper SC, Flaitz CM, Johnston DA, Lee B, Hecht JT. A natural history of cleidocranial dysplasia. Am J Med Genet. 2001;104(1):1–6.CrossRef
5.
go back to reference The classic: Marie P., and Sainton P.: Sur la dysostose cleido-cranienne herediataire, Rev. neurol. 6:835, 1898. On hereditary cleido-cranial dysostosis. Clin Orthop Relat Res 1968, 58:5–7. The classic: Marie P., and Sainton P.: Sur la dysostose cleido-cranienne herediataire, Rev. neurol. 6:835, 1898. On hereditary cleido-cranial dysostosis. Clin Orthop Relat Res 1968, 58:5–7.
6.
go back to reference Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, Albright S, Lindhout D, Cole WG, Henn W, Knoll JH, et al. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell. 1997;89(5):773–9.CrossRef Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, Albright S, Lindhout D, Cole WG, Henn W, Knoll JH, et al. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell. 1997;89(5):773–9.CrossRef
7.
go back to reference El-Gharbawy AH, Peeden JN Jr, Lachman RS, Graham JM Jr, Moore SR, Rimoin DL. Severe cleidocranial dysplasia and hypophosphatasia in a child with microdeletion of the C-terminal region of RUNX2. Am J Med Genet A. 2010;152A(1):169–74.CrossRef El-Gharbawy AH, Peeden JN Jr, Lachman RS, Graham JM Jr, Moore SR, Rimoin DL. Severe cleidocranial dysplasia and hypophosphatasia in a child with microdeletion of the C-terminal region of RUNX2. Am J Med Genet A. 2010;152A(1):169–74.CrossRef
8.
go back to reference Gelb BD, Cooper E, Shevell M, Desnick RJ. Genetic mapping of the cleidocranial dysplasia (CCD) locus on chromosome band 6p21 to include a microdeletion. Am J Med Genet. 1995;58(2):200–5.CrossRef Gelb BD, Cooper E, Shevell M, Desnick RJ. Genetic mapping of the cleidocranial dysplasia (CCD) locus on chromosome band 6p21 to include a microdeletion. Am J Med Genet. 1995;58(2):200–5.CrossRef
9.
go back to reference Callea M, Bellacchio E, Fattori F, Bertini E, Callea F, Cammarata-Scalisi F. Acute myeloid leukemia in a 3 years old child with cleidocranial dysplasia. Leuk Lymphoma. 2016;57(9):2189–91.CrossRef Callea M, Bellacchio E, Fattori F, Bertini E, Callea F, Cammarata-Scalisi F. Acute myeloid leukemia in a 3 years old child with cleidocranial dysplasia. Leuk Lymphoma. 2016;57(9):2189–91.CrossRef
10.
go back to reference Kelkar PS, Ten RM. Association of humoral immunodeficiency, cleidocranial dysplasia, and von Willebrand's disease in a family cluster. J Allergy Clin Immunol. 2001;107(4):742.CrossRef Kelkar PS, Ten RM. Association of humoral immunodeficiency, cleidocranial dysplasia, and von Willebrand's disease in a family cluster. J Allergy Clin Immunol. 2001;107(4):742.CrossRef
11.
go back to reference Alexander WN, Ferguson RL. Beta thalassemia minor and cleidocranial dysplasia: a rare combination of genetic abnormalities in one family. Oral Surg Oral Med Oral Pathol. 1980;49(5):413–8.CrossRef Alexander WN, Ferguson RL. Beta thalassemia minor and cleidocranial dysplasia: a rare combination of genetic abnormalities in one family. Oral Surg Oral Med Oral Pathol. 1980;49(5):413–8.CrossRef
12.
go back to reference Dincsoy Bir F, Dinckan N, Guven Y, Bas F, Altunoglu U, Kuvvetli SS, Poyrazoglu S, Toksoy G, Kayserili H, Uyguner ZO. Cleidocranial dysplasia: clinical, endocrinologic and molecular findings in 15 patients from 11 families. Eur J Med Genet. 2017;60(3):163–8.CrossRef Dincsoy Bir F, Dinckan N, Guven Y, Bas F, Altunoglu U, Kuvvetli SS, Poyrazoglu S, Toksoy G, Kayserili H, Uyguner ZO. Cleidocranial dysplasia: clinical, endocrinologic and molecular findings in 15 patients from 11 families. Eur J Med Genet. 2017;60(3):163–8.CrossRef
13.
go back to reference Bharti K, Goswami M. Cleidocranial dysplasia: a report of two cases with brief review. Intractable Rare Dis Res. 2016;5(2):117–20.CrossRef Bharti K, Goswami M. Cleidocranial dysplasia: a report of two cases with brief review. Intractable Rare Dis Res. 2016;5(2):117–20.CrossRef
14.
go back to reference Nakahara I, Nozaki K, Ishikawa J. [a case of cleidocranial dysostosis associated with arachnoid cyst]. No shinkei geka. Neurol Surg. 1987;15(11):1241–6. Nakahara I, Nozaki K, Ishikawa J. [a case of cleidocranial dysostosis associated with arachnoid cyst]. No shinkei geka. Neurol Surg. 1987;15(11):1241–6.
15.
go back to reference Tress BM, Mosely IF. Cleidocranial dysostosis, hereditary haemorrhagic telangiectasia and epilepsy: a rare association. Neuroradiology. 1977;12(4):233–6.CrossRef Tress BM, Mosely IF. Cleidocranial dysostosis, hereditary haemorrhagic telangiectasia and epilepsy: a rare association. Neuroradiology. 1977;12(4):233–6.CrossRef
16.
go back to reference Oyer CE, Tatevosyants NG, Cortez SC, Hornstein A, Wallach M. Cleidocranial dysplasia with neonatal death due to central nervous system injury in utero: case report and literature review. Pediatr Dev Pathol. 1998;1(4):314–8.CrossRef Oyer CE, Tatevosyants NG, Cortez SC, Hornstein A, Wallach M. Cleidocranial dysplasia with neonatal death due to central nervous system injury in utero: case report and literature review. Pediatr Dev Pathol. 1998;1(4):314–8.CrossRef
17.
go back to reference Weijenberg A, Brouwer OF, Callenbach PM. Levetiracetam monotherapy in children with epilepsy: a systematic review. CNS drugs. 2015;29(5):371–82.CrossRef Weijenberg A, Brouwer OF, Callenbach PM. Levetiracetam monotherapy in children with epilepsy: a systematic review. CNS drugs. 2015;29(5):371–82.CrossRef
18.
go back to reference Tekgul H, Gencpinar P, Cavusoglu D, Dundar NO. The efficacy, tolerability and safety of levetiracetam therapy in a pediatric population. Seizure. 2016;36:16–21.CrossRef Tekgul H, Gencpinar P, Cavusoglu D, Dundar NO. The efficacy, tolerability and safety of levetiracetam therapy in a pediatric population. Seizure. 2016;36:16–21.CrossRef
19.
go back to reference Bailet LL, Turk WR. The impact of childhood epilepsy on neurocognitive and behavioral performance: a prospective longitudinal study. Epilepsia. 2000;41(4):426–31.CrossRef Bailet LL, Turk WR. The impact of childhood epilepsy on neurocognitive and behavioral performance: a prospective longitudinal study. Epilepsia. 2000;41(4):426–31.CrossRef
20.
go back to reference Wakamoto H, Nagao H, Hayashi M, Morimoto T. Long-term medical, educational, and social prognoses of childhood-onset epilepsy: a population-based study in a rural district of Japan. Brain Dev. 2000;22(4):246–55.CrossRef Wakamoto H, Nagao H, Hayashi M, Morimoto T. Long-term medical, educational, and social prognoses of childhood-onset epilepsy: a population-based study in a rural district of Japan. Brain Dev. 2000;22(4):246–55.CrossRef
21.
go back to reference Aldenkamp AP, Weber B, Overweg-Plandsoen WC, Reijs R, van Mil S. Educational underachievement in children with epilepsy: a model to predict the effects of epilepsy on educational achievement. J Child Neurol. 2005;20(3):175–80.CrossRef Aldenkamp AP, Weber B, Overweg-Plandsoen WC, Reijs R, van Mil S. Educational underachievement in children with epilepsy: a model to predict the effects of epilepsy on educational achievement. J Child Neurol. 2005;20(3):175–80.CrossRef
Metadata
Title
Cleidocranial dysplasia syndrome with epilepsy: a case report
Authors
Yimei Ma
Fumin Zhao
Dan Yu
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2019
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-019-1472-0

Other articles of this Issue 1/2019

BMC Pediatrics 1/2019 Go to the issue